This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

This evanescent but critical antigen-binding site made RSV vaccine development difficult. However, mRNA technology allows “more hypothesis-driven complex vaccine design”, says Carfi ...

Vaxxas, has announced the company has been granted a licence to develop a next-generation vaccine antigen (DS2).

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that the United States National Institutes of Health ...

Respiratory syncytial virus cases are rising all over the country ... In Florida, 24.3% of antigen tests and 23.9% of PCR tests taken the week of Nov. 11 were positive—a seismic increase from ...

The immune system remembers how to protect the body against this antigen in the future. If the body encounters RSV later, the immune system will be able to quickly recognize the virus and disable ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

Rapid antigen-based testing was quickly embraced ... For these reasons, it is the most widely used diagnostic test for RSV. RADTs are rapid immunoassays and are available from a variety of ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that the United States National Institutes of ...